THAP9-AS1

gene
On this page

Summary

THAP9-AS1 (THAP9 antisense RNA 1, HGNC:44172) is a long non-coding RNA gene on chromosome 4q21.22.

Predicted to act upstream of or within response to wounding.

Source: NCBI Gene 100499177 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:44172
Approved symbolTHAP9-AS1
NameTHAP9 antisense RNA 1
Location4q21.22
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000251022
Ensembl biotypelncRNA
Entrez100499177
RNAcentralURS000075EF75 — lncRNA, 2318 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 12 lncRNA

ENST00000503704, ENST00000504520, ENST00000504718, ENST00000504792, ENST00000504869, ENST00000505028, ENST00000507660, ENST00000508772, ENST00000509007, ENST00000511271, ENST00000512932, ENST00000513581

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000503704 — 2 exons

ExonStartEnd
ENSE000020866248289982382900223
ENSE000035482948290033482900569

Expression profiles

Bgee: expression breadth ubiquitous, 283 present calls, max score 96.01.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.0376 / max 504.2526, expressed in 1733 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
5289715.03761733
528969.89841564

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370196.01gold quality
rectumUBERON:000105295.14gold quality
tibial nerveUBERON:000132395.06gold quality
skin of abdomenUBERON:000141694.31gold quality
left ovaryUBERON:000211994.13gold quality
left lobe of thyroid glandUBERON:000112093.94gold quality
thyroid glandUBERON:000204693.52gold quality
ectocervixUBERON:001224993.51gold quality
metanephros cortexUBERON:001053393.50gold quality
minor salivary glandUBERON:000183093.42gold quality
right lungUBERON:000216793.41gold quality
epithelium of nasopharynxUBERON:000195193.37gold quality
cortical plateUBERON:000534393.30gold quality
skin of legUBERON:000151193.29gold quality
tendonUBERON:000004393.27gold quality
monocyteCL:000057693.23gold quality
ventricular zoneUBERON:000305393.21gold quality
subcutaneous adipose tissueUBERON:000219093.16gold quality
endometriumUBERON:000129593.15gold quality
right ovaryUBERON:000211893.13gold quality
right lobe of thyroid glandUBERON:000111993.12gold quality
mononuclear cellCL:000084293.11gold quality
ganglionic eminenceUBERON:000402393.10gold quality
body of uterusUBERON:000985392.89gold quality
zone of skinUBERON:000001492.79gold quality
cerebellar hemisphereUBERON:000224592.58gold quality
leukocyteCL:000073892.57gold quality
mouth mucosaUBERON:000372992.52gold quality
cerebellar cortexUBERON:000212992.49gold quality
right hemisphere of cerebellumUBERON:001489092.49gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.14

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 5)

  • lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP. (PMID:31831555)
  • Long Noncoding RNA THAP9-AS1 and TSPOAP1-AS1 Provide Potential Diagnostic Signatures for Pediatric Septic Shock. (PMID:33344646)
  • The role of long noncoding RNA THAP9-AS1 in the osteogenic differentiation of dental pulp stem cells via the miR-652-3p/VEGFA axis. (PMID:34288157)
  • LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. (PMID:36170961)
  • THAP9-AS1 promotes nasopharyngeal carcinoma progression through targeted regulation of the miR-185-5p/SOX13 axis. (PMID:38270621)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.